BABA vs DHI

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

DHI exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a fortress balance sheet characterized by a very low Debt/Equity ratio of 0.27. However, the company is currently facing a cyclical downturn, evidenced by negative YoY revenue (-2.30%) and earnings growth (-13.20%). While the stock is reasonably priced on a P/E basis (15.01), it trades at a premium to its Graham Number ($140.96) and significantly above its growth-based intrinsic value ($74.55). The combination of strong fundamentals and deteriorating growth metrics warrants a neutral stance.